NCT04441021View on ClinicalTrials.gov

Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

June 29, 2021

Conditions
Penicillin Allergy
Interventions
OTHER

Penicillin Allergy Risk Stratification and Evaluation

This standard of care intervention will provide an antibiotic allergy risk stratification assessment and subsequent amoxicillin oral challenge in patients who stratify as low risk for true allergy

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Vanderbilt University Medical Center

OTHER

NCT04441021 - Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy | Biotech Hunter | Biotech Hunter